NRNP 6665 - Mid Term exam Seraphin- -with with 100% verified solutions

10/19/23, z1:54 2021 zMid zTerm zNRNP
zAM z6665 z1




2021 zMidTerm zSeraphin

Question z1
Biofeedback, zdeep zbreathing, zmindfulness, zand zprogressive zmuscle zrelaxation zare
zstrategies
that zare ztypically zused zin zwhich zof zthe zfollowing ztherapies?

A zRelaxation ztherapy
.
B zSocial zskills ztraining
.
C zMotivational
Interviewing
. z
D zApplied
zbehavioral
zanalysis
.

Question z2
According zto zthe zAPA zwhich zof zthe zfollowing zare zrequired zto
zsupport za zchild’s zDSM- z5 zdiagnosis?
A zThe zchild’s zclinical zpresentation zfulfills zthe zspecific zsymptom
zbased zdiagnostic zcriteria.
.
B zThe zchild’s zsymptoms zare znot zcaused zby zother zdiagnoses zor zstressors.
.
C zThe zchild’s zsymptoms zare zimpairing za zchild’s zfunctioning zin
zat zleast ztwo zsettings.
.
D zA zand zB
.

Question z3
Which zof zthe zfollowing zis zNOT zconsistent zwith zgood zsleep zhygiene?
A zAllow zchild zto zkeep za zcell zphone zat zbedside.
.
B zEstablish zbedtime zroutines zand zmaintain zconsistently.
.
C zLimit zuse zof zelectronics zin zthe zevening
zi.e., ztelevision, zcomputer, zetc.
.
D zSet z and z maintain z a z bedtime z that z will z allow z for z adequate
. z sleep.

Question z4
Which zof zthe zfollowing zantipsychotic zmedications zhave zthe zgreatest ztendency
zto zincrease zappetite zand zbody zweight?




about:blank 1/31

,10/19/23, z1:54 2021 zMid zTerm zNRNP
zAM z6665 z1




A zAripiprazole z(Abilify)
.
B
zZiprasidon
e z(Geodon)
.
C zHaloperidol z(Haldol)
.
D
Risperidon
z
e
z(Risperdal)
.

Question z5
When zassessing za zchild zwith zdisruptive zor zaggressive zbehavior, zthe zclinician zasks
z“Have zyou
been zthinking zabout zor zplanning zto zhurt zanyone?” zto zscreen zfor
zwhich zof zthe zfollowing zdiagnostic zcategories?
A zSafety
.
B zBullying
.
C zConduct zdisorder
.
D zOppositional zdefiant
. z disorder

Question z6
The zclinician zassessing zsubstance zabuse zin zan zadolescent zasks, z“Did zyou
zdevelop zmore zmood zor zanxiety zproblems zafter zyou zstarted zusing?” zto
zscreen zfor zwhich zof zthe zfollowing zdiagnostic
possibilities?

A zSubstance zuse zdisorder
.
B zSubstance zwithdrawal
.
C zSubstance ztolerance
.
D zSubstance zinduced zmental
zdisorder
.

Question z7
When zthe zpatient zlacks zcapacity zto zmake za zdecision zthe znurse zhas zthe zethical
zresponsibility
to zdo zwhich zof zthe zfollowing?

A zBecome za zsurrogate zdecision zmaker zfor zthe zpatient.
.
B zConsult za zformally-designated zsurrogate zfor zpatient zchoices.




about:blank 2/31

,10/19/23, z1:54 2021 zMid zTerm zNRNP
zAM z6665 z1




.
C zMake zsafe zchoices zfor zthe zpatient zbased zon zthe
znurse’s zbeliefs zand zvalues.
.
D zContinue zto zsupport zall zthe zpatient’s zchoices zuntil za zsurrogate
can zbe zfound.
. z

Question z8
When zassessing za zchild zwho zhas zpresented zwith zconcerns zof zbeing zanxious
zand zworried, zthe zprovider zasks zthe zchild z“Do zyou zget zsudden zsurges zof
zfear zthat zmake zyour zbody zfeel zshaky zor
your zheart zrace?” zto zscreen zfor zwhich zof zthe zfollowing zcommon zdiagnostic
zpossibilities?

A zObsessive z-
compulsive zdisorder
.
B zPosttraumatic
zstress zdisorder
.
C zPanic zdisorder
.
D zSeparation
z anxiety zdisorder
.

Question z9
Which zof zthe zfollowing zantipsychotic zmedications zhas zthe zgreatest zrisk zfor zweight
zgain zand
lipid zchanges?

A
zZiprasidon
e z(Geodon)
.
B zAripiprazole
. z (Abilify)
C
z Olanzapin
e
z(Zyprexa)
.
D
zQuetiapin
e
z(Seroquel
)
.

Question z10
A zperiod zof zat zleast zone zweek zin zwhich zboth za zmanic zepisode zand za zmajor
zdepressive zepisode
occur zalmost zdaily zis zconsistent zwith zwhich zdiagnosis?
A zBipolar zII zDisorder
.
B zCyclothymic zDisorder
.




about:blank 3/31

, 10/19/23, z1:54 2021 zMid zTerm zNRNP
zAM z6665 z1




C zBipolar zI zDisorder,
zmixed zepisode
.

D zBipolar z I z Disorder,
z cyclothymic ztype
.

Question z11
Which zof zthe zfollowing zis zNOT ztrue zabout zsymptomatology zof zanorexia znervosa?
A zMost zaberrant zbehaviors zdirected ztoward zlosing zweight zoccurs zin zsecret.
.
B zAll zpatients zhave zan zintense zfear zof zgaining zweight zand zbecoming zobese.
.
C zMost zpatients zwith zanorexia znervosa zwill zhave zno zdi昀케culty zeating
zwith ztheir zfamily zin zpublic zplaces.
.

D zFear zof zgaining zweight zand zbecoming zobese zfrequently zcontributes zto
zthe zindividual’s zlack zof zinterest zin zand zresistance zto
ztherapy/treatment.
.

Question z12
Sleep-related zhallucinations zoccurring zat zsleep zonset zare zknown zas zwhich zof zthe
zfollowing?
A zHypnagogic
.
B z
Hypnopompic
.
C zComplex
zhallucinatio
ns
.
D zParanormal
. z hallucinations

Question z13
The ztheory zthat zdepression zresults zfrom zspeci昀椀c zthought zdistortions zis
zconsistent zwith zwhich zof zthe zfollowing?
A zCognitive ztheory
.
B zPsychosocial ztheory
.
C zPsychodynamic ztheory
.
D zLearned zhelplessness
. z theory




about:blank 4/31